The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vallourec SA
OTC:VLOWY
|
FR |
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
IN |
|
S
|
Southern Co
DUS:SOT
|
US |
|
Airbus SE
MIL:1AIR
|
NL |
|
Kimberly-Clark de Mexico SAB de CV
F:4FX
|
MX |
|
Nomura Research Institute Ltd
TSE:4307
|
JP |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
SWB:RER1
|
IT |
|
Fujiya Co Ltd
TSE:2211
|
JP |
|
MNC Kapital Indonesia Tbk PT
IDX:BCAP
|
ID |
|
Marui Group Co Ltd
TSE:8252
|
JP |
|
Amcor PLC
F:485B
|
UK |
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
D
|
Deutsche Boerse AG
XMUN:DB1
|
DE |
|
Maruchiyo Yamaokaya Corp
TSE:3399
|
JP |
|
T
|
Talgo SA
SWB:XTG
|
ES |
|
Konami Group Corp
F:KOA0
|
JP |
|
Sanyo Electric Railway Co Ltd
TSE:9052
|
JP |
|
McCormick & Company Inc
F:MCX0
|
US |
|
Wuchan Zhongda Group Co Ltd
SSE:600704
|
CN |
|
S
|
Swiss Re AG
SWB:SR9
|
CH |
|
Huntington Bancshares Inc
NASDAQ:HBAN
|
US |
|
Groupe Pizzorno Environnement SA
PAR:GPE
|
FR |
|
I
|
Inpro SA
WSE:INP
|
PL |
|
P
|
PNC Financial Services Group Inc
LSE:0KEF
|
US |
Vallourec SA (VLOWY)’s 12-month stock price forecast through October 2027 has a consensus target of $6.24, implying 54% upside. The forecast is based on price targets from 15 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for VLOWY is 6.24 USD with a low forecast of 4.92 USD and a high forecast of 7.14 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 5 years is 7%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 5 years is 8%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 5 years is 10%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 20%.
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 22%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more